Cubist Systematic Strategies, LLC Amneal Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $18,313 - $22,158	3,495 New	3,495 $21,000
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $665 - $1,106	241 New	241 $1,000
Q1 2023 May 15, 2023	SELL	$1.27 - $2.7 $42,701 - $90,782	-33,623 Reduced 51.8%	31,291 $43,000
Q4 2022 Feb 14, 2023	SELL	$1.96 - $2.61 $136,200 - $181,368	-69,490 Reduced 51.7%	64,914 $129,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $248,399 - $445,151	122,970 Added 1075.48%	134,404 $271,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $13,231 - $19,606	-4,396 Reduced 27.77%	11,434 $36,000
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $144,966 - $181,766	-37,171 Reduced 70.13%	15,830 $66,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $148,271 - $219,591	-37,537 Reduced 41.46%	53,001 $254,000
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $232,722 - $304,537	53,996 Added 147.76%	90,538 $483,000
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $1.3 Million - $1.73 Million	-253,754 Reduced 87.41%	36,542 $187,000
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $1.15 Million - $1.79 Million	241,886 Added 499.66%	290,296 $1.95 Million
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $195,461 - $268,203	-49,484 Reduced 50.55%	48,410 $221,000
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $105,789 - $157,488	-29,884 Reduced 23.39%	97,894 $380,000
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $307,222 - $584,471	107,046 Added 516.33%	127,778 $608,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $8,049 - $17,505	-3,272 Reduced 13.63%	20,732 $72,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $107,044 - $224,590	-40,394 Reduced 62.73%	24,004 $116,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $234,379 - $726,677	-102,349 Reduced 61.38%	64,398 $187,000
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $980,483 - $2.18 Million	152,249 Added 1050.14%	166,747 $1.2 Million
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $651,651 - $814,701	-54,899 Reduced 79.11%	14,498 $205,000
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $408,499 - $670,638	-31,207 Reduced 31.02%	69,397 $939,000
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $965,812 - $1.43 Million	58,891 Added 141.18%	100,604 $2.23 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $581,896 - $842,602	41,713 New	41,713 $685,000

Others Institutions Holding AMRX

# of Institutions

184

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account